問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberNH002-LV-02
Active

2024-01-01 - 2026-12-31

Phase III

Not yet recruiting1

Recruiting5

  • Trial Applicant

    CMIC Asia-Pacific

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator 洪崇烈 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 黃文弘 Division of Cardiovascular Diseases
  • 宋國慈 Division of Cardiovascular Diseases
  • 蕭智忠 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Wen-Chung Yu Division of Cardiovascular Diseases

Co-Principal Investigator

  • 李慶威 Division of Cardiovascular Diseases
  • 黃偉銘 Division of Cardiovascular Diseases
  • Tze-Fan Chao Division of Cardiovascular Diseases
  • 廖若男 Division of Cardiovascular Diseases
  • 郭泠 Division of Cardiovascular Diseases
  • 王維庭 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 秦志輝 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 簡韶甫 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 梁馨月 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 吳宏彬 Division of Cardiovascular Diseases
  • 賴怡青 Division of Cardiovascular Diseases
  • 鄭英男 Division of Cardiovascular Diseases
  • 董承昌 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 楊甯貽 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 郭李堂 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 楊欽文 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 李志國 Division of Cardiovascular Diseases
  • 劉聖甫 Division of Cardiovascular Diseases
  • 黃冠智 Division of Cardiovascular Diseases
  • 曾新育 Division of Cardiovascular Diseases
  • 葉洛嘉 Division of Cardiovascular Diseases
  • 余安立 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    150 participants

  • Global

    150 participants